Inter- and Intraindividual Variability in Ketamine Dosage in Repetitive Invasive Procedures in Children with Malignancies

Midazolam/ketamine sedation has been used successfully in children undergoing painful invasive procedures. The authors prospectively assessed inter- and intra-individual variability in ketamine dosage for sedation in repetitive invasive procedures in children with malignancies. A total of 92 invasive procedures (58 lumbar punctures, 34 bone marrow biopsies; range: 2–9 procedures/patient) were performed on 25 children (median age: 12 years). Intravenous sedation consisted of 0.1 mg midazolam/kg and 0.5–1.0 mg ketamine/kg. Incremental dosages of ketamine (0.33 mg/kg) were given if necessary to achieve or maintain deep sedation. Primary outcome measure was the inter- and intraindividual ketamine dosage required to achieve adequate sedation; secondary outcome measures were the number of procedures with adequate sedation (Ramsay score of >4), the number of adverse side effects, and the need for therapeutic interventions. All 92 invasive procedures were completed with satisfactory sedation levels in 88 procedures (95.7%). There was a great inter- and intraindividual variability in ketamine dosage required to achieve or maintain adequate sedation. In 12% of procedures side effects were seen, which required no or only minor interventions. Due to great inter- and intraindividual differences, ketamine dosage should be titrated toward the desired level of sedation. Thus, ketamine can be adjusted to the individual's need while achieving adequate sedation.

[1]  M. Sagy,et al.  Pediatric sedation for procedures titrated to a desired degree of immobility results in unpredictable depth of sedation. , 2001, Pediatric emergency care.

[2]  T. Gordh,et al.  Lumbar puncture in pediatric oncology: conscious sedation vs. general anesthesia. , 2001, Medical and pediatric oncology.

[3]  A. Shad,et al.  Prospective Evaluation of Propofol Anesthesia in the Pediatric Intensive Care Unit for Elective Oncology Procedures in Ambulatory and Hospitalized Children , 2000, Pediatrics.

[4]  M. Parker,et al.  Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. , 1997, Pediatrics.

[5]  S. Shurin,et al.  Ketamine-midazolam versus meperidine-midazolam for painful procedures in pediatric oncology patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Coté,et al.  Practice Guidelines for Sedation and Analgesia by Non-Anesthesiologists , 2002, Anesthesiology.

[7]  C. Elliott,et al.  A comparative study of cognitive behavior therapy versus general anesthesia for painful medical procedures in children , 1995, Pain.

[8]  S. Weisman,et al.  The use of oral transmucosal fentanyl citrate for painful procedures in children. , 1995, Pediatrics.

[9]  R. Hackbarth,et al.  Brief unconscious sedation for painful pediatric oncology procedures. Intravenous methohexital with appropriate monitoring is safe and effective. , 1993, The American journal of pediatric hematology/oncology.

[10]  R. Mulhern,et al.  Oral ketamine premedication to alleviate the distress of invasive procedures in pediatric oncology patients. , 1992, Pediatrics.

[11]  S. McGorray,et al.  Midazolam versus fentanyl as premedication for painful procedures in children with cancer. , 1991, Pediatrics.

[12]  C. Berde,et al.  Midazolam for conscious sedation during pediatric oncology procedures: safety and recovery parameters. , 1991, Pediatrics.

[13]  M. Ramsay,et al.  Controlled Sedation with Alphaxalone-Alphadolone , 1974, British medical journal.